These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35402559)

  • 1. Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis.
    Fang C; Zuo K; Fu Y; Li J; Wang H; Xu L; Yang X
    Front Cardiovasc Med; 2022; 9():832092. PubMed ID: 35402559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis.
    Fu Y; Yang Y; Fang C; Liu X; Dong Y; Xu L; Chen M; Zuo K; Wang L
    Front Cardiovasc Med; 2022; 9():944155. PubMed ID: 36110409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury.
    Fang C; Zuo K; Jiao K; Zhu X; Fu Y; Zhong J; Xu L; Yang X
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights.
    Song Y; Wei H; Zhou Z; Wang H; Hang W; Wu J; Wang DW
    Front Med; 2024 Feb; 18(1):31-45. PubMed ID: 38424375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Gut Bacteria-Derived Metabolite Phenylacetylglutamine in Health and Diseases.
    Krishnamoorthy NK; Kalyan M; Hediyal TA; Anand N; Kendaganna PH; Pendyala G; Yelamanchili SV; Yang J; Chidambaram SB; Sakharkar MK; Mahalakshmi AM
    ACS Omega; 2024 Jan; 9(3):3164-3172. PubMed ID: 38284070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure.
    Zhang Z; Cai B; Sun Y; Deng H; Wang H; Qiao Z
    Front Cardiovasc Med; 2022; 9():1076806. PubMed ID: 36704458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiome-Generated Phenylacetylglutamine from Dietary Protein is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Model Possibly via Platelet Activation.
    Feng R; Tian Z; Mao R; Ma R; Luo W; Zhao M; Li X; Liu Y; Huang K; Xiang L; Zhuang X; Huo B; Yu T; Chen S; Chen M; Zhu Y
    J Crohns Colitis; 2023 Nov; 17(11):1833-1846. PubMed ID: 37350766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
    Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure.
    Romano KA; Nemet I; Prasad Saha P; Haghikia A; Li XS; Mohan ML; Lovano B; Castel L; Witkowski M; Buffa JA; Sun Y; Li L; Menge CM; Demuth I; König M; Steinhagen-Thiessen E; DiDonato JA; Deb A; Bäckhed F; Tang WHW; Naga Prasad SV; Landmesser U; Van Wagoner DR; Hazen SL
    Circ Heart Fail; 2023 Jan; 16(1):e009972. PubMed ID: 36524472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors.
    Nemet I; Saha PP; Gupta N; Zhu W; Romano KA; Skye SM; Cajka T; Mohan ML; Li L; Wu Y; Funabashi M; Ramer-Tait AE; Naga Prasad SV; Fiehn O; Rey FE; Tang WHW; Fischbach MA; DiDonato JA; Hazen SL
    Cell; 2020 Mar; 180(5):862-877.e22. PubMed ID: 32142679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut-Derived Metabolite Phenylacetylglutamine and White Matter Hyperintensities in Patients With Acute Ischemic Stroke.
    Yu F; Feng X; Li X; Luo Y; Wei M; Zhao T; Xia J
    Front Aging Neurosci; 2021; 13():675158. PubMed ID: 34393756
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value of gut microbe-generated metabolite phenylacetylglutamine in patients with heart failure.
    Tang WHW; Nemet I; Li XS; Wu Y; Haghikia A; Witkowski M; Koeth RA; Demuth I; König M; Steinhagen-Thiessen E; Bäckhed F; Fischbach MA; Deb A; Landmesser U; Hazen SL
    Eur J Heart Fail; 2024 Feb; 26(2):233-241. PubMed ID: 38124458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV.
    Trøseid M; Molinaro A; Gelpi M; Vestad B; Kofoed KF; Fuchs A; Køber L; Holm K; Benfield T; Ueland PM; Hov JR; Nielsen SD; Knudsen AD
    J Infect Dis; 2024 Mar; 229(3):898-907. PubMed ID: 38195204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.
    Zhang T; Ren H; Du Z; Zou T; Guang X; Zhang Y; Tian Y; Zhu L; Yu J; Yu X; Zhang Z; Dai H
    Microbiol Spectr; 2022 Dec; 10(6):e0280422. PubMed ID: 36301099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease.
    Ottosson F; Brunkwall L; Smith E; Orho-Melander M; Nilsson PM; Fernandez C; Melander O
    J Hypertens; 2020 Dec; 38(12):2427-2434. PubMed ID: 32665522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease.
    Zhu Y; Dwidar M; Nemet I; Buffa JA; Sangwan N; Li XS; Anderson JT; Romano KA; Fu X; Funabashi M; Wang Z; Keranahalli P; Battle S; Tittle AN; Hajjar AM; Gogonea V; Fischbach MA; DiDonato JA; Hazen SL
    Cell Host Microbe; 2023 Jan; 31(1):18-32.e9. PubMed ID: 36549300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylacetylglutamine, a Novel Biomarker in Acute Ischemic Stroke.
    Yu F; Li X; Feng X; Wei M; Luo Y; Zhao T; Xiao B; Xia J
    Front Cardiovasc Med; 2021; 8():798765. PubMed ID: 35004911
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in the gut microbiome and metabolism with coronary artery disease severity.
    Liu H; Chen X; Hu X; Niu H; Tian R; Wang H; Pang H; Jiang L; Qiu B; Chen X; Zhang Y; Ma Y; Tang S; Li H; Feng S; Zhang S; Zhang C
    Microbiome; 2019 Apr; 7(1):68. PubMed ID: 31027508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure.
    Zong X; Fan Q; Yang Q; Pan R; Zhuang L; Tao R
    ESC Heart Fail; 2022 Aug; 9(4):2645-2653. PubMed ID: 35624536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Phenylacetylglutamine on the Susceptibility of Atrial Fibrillation in Overpressure-Induced HF Mice.
    Fu H; Li D; Shuai W; Kong B; Wang X; Tang Y; Huang H; Huang C
    Mol Cell Biol; 2024; 44(4):149-163. PubMed ID: 38725392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.